Brooks O'Neil
Stock Analyst at Lake Street
(1.71)
# 1,769
Out of 4,667 analysts
26
Total ratings
45.45%
Success rate
-5.83%
Average return
Main Sectors:
Stocks Rated by Brooks O'Neil
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HROW Harrow | Maintains: Buy | $45 → $55 | $42.44 | +29.59% | 3 | Oct 4, 2024 | |
| MODV ModivCare | Maintains: Buy | $50 → $30 | $16.31 | +83.94% | 2 | Sep 17, 2024 | |
| ATEC Alphatec Holdings | Maintains: Buy | $32 → $18 | $9.93 | +81.27% | 4 | Sep 3, 2024 | |
| ORGO Organogenesis Holdings | Initiates: Buy | $5 | $3.97 | +25.94% | 1 | Jun 28, 2024 | |
| SRDX Surmodics | Downgrades: Hold | $43 | $39.17 | +9.78% | 3 | May 29, 2024 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $60 → $75 | $30.15 | +148.76% | 1 | May 22, 2024 | |
| PIII P3 Health Partners | Maintains: Buy | $9 → $4.5 | $0.20 | +2,108.05% | 1 | Mar 14, 2024 | |
| MDXG MiMedx Group | Initiates: Buy | $12 | $9.06 | +32.45% | 1 | Mar 7, 2024 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $65 → $75 | $103.44 | -27.49% | 1 | Aug 2, 2023 | |
| RCEL AVITA Medical | Maintains: Buy | $30 → $40 | $13.05 | +206.51% | 5 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $26 | $29.21 | -10.99% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $45 | $2.92 | +1,441.10% | 1 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $2.06 | +433.98% | 1 | Apr 8, 2022 |
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $55
Current: $42.44
Upside: +29.59%
ModivCare
Sep 17, 2024
Maintains: Buy
Price Target: $50 → $30
Current: $16.31
Upside: +83.94%
Alphatec Holdings
Sep 3, 2024
Maintains: Buy
Price Target: $32 → $18
Current: $9.93
Upside: +81.27%
Organogenesis Holdings
Jun 28, 2024
Initiates: Buy
Price Target: $5
Current: $3.97
Upside: +25.94%
Surmodics
May 29, 2024
Downgrades: Hold
Price Target: $43
Current: $39.17
Upside: +9.78%
Tandem Diabetes Care
May 22, 2024
Maintains: Buy
Price Target: $60 → $75
Current: $30.15
Upside: +148.76%
P3 Health Partners
Mar 14, 2024
Maintains: Buy
Price Target: $9 → $4.5
Current: $0.20
Upside: +2,108.05%
MiMedx Group
Mar 7, 2024
Initiates: Buy
Price Target: $12
Current: $9.06
Upside: +32.45%
LeMaitre Vascular
Aug 2, 2023
Maintains: Buy
Price Target: $65 → $75
Current: $103.44
Upside: -27.49%
AVITA Medical
Jul 13, 2023
Maintains: Buy
Price Target: $30 → $40
Current: $13.05
Upside: +206.51%
Feb 15, 2023
Maintains: Buy
Price Target: $20 → $26
Current: $29.21
Upside: -10.99%
Nov 21, 2022
Assumes: Buy
Price Target: $45
Current: $2.92
Upside: +1,441.10%
Apr 8, 2022
Initiates: Buy
Price Target: $11
Current: $2.06
Upside: +433.98%